Connect with us

Business

Novartis halts hydroxychloroquine trial after FDA yanks approval – New York Post

A Swiss pharmaceutical company has stopped a clinical trial for hydroxychloroquine — a decision that comes days after the FDA yanked its emergency approval to use the drug to treat coronavirus. The…

post featured image
ADVERTISEMENT

A Swiss pharmaceutical company has stopped a clinical trial for hydroxychloroquine a decision that comes days after the FDA yanked its emergency approval to use the drug to treat coronavirus.
The co…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Bacon may disappear in California as pig rules take effect – KCRA Sacramento
Article feature image
DoorDash Drivers Go On Strike – NPR
Article feature image
Pet food recalled after products potentially contaminated with mold toxins, FDA announces – KSAT San Antonio